Stryker Rides Wave as New Products See Continued Adoption
Stryker continues to enjoy extensive financial flexibility, even as it has issued more debt to finance the purchase of some larger acquisitions. At the end of 2024, the firm's net debt/EBITDA was 1.9 ...
MassDevice1d
Stryker launches next-gen Mako suite
Stryker (NYSE: SYK) announced today that it is commercially launching the next generation of its Mako surgical robotic ...
Medical Device Network on MSN2d
FDA grants 510(k) clearance to Zimmer’s new revision knee implant component
The US Food and Drug Administration (FDA) has granted 510(k) clearance to Zimmer Biomet's new revision knee implant component ...
MassDevice5d
FDA clears revision knee implant from Zimmer Biomet
Zimmer Biomet (NYSE: ZBH) announced today that it received FDA 510(k) clearance for its Persona Revision SoluTion Femur.